Flavan-3-ol esters: New agents for exploring modulatory sites on GABA A receptors

British Journal of Pharmacology

Volumn 165, Issue 4, 2012, Pages 965-977

  Fernandez, Sebastian P ^a,c   Karim, Nasiara ^b   Mewett, Kenneth N ^a   Chebib, Mary ^b   Johnston, Graham A R ^a   Hanrahan, Jane R ^b  

^a University of Sydney   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c INSTITUT DU FER À MOULIN   (France)

Author keywords

1 containing GABA A receptors; anaesthetic agents; flavans; flavonoids; GABA ( aminobutyric acid); GABA A receptors; sedative effects; Xenopus oocytes

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1BETA2GAMMA2L; CIS 3 ACETOXY 3',4' DIMETHOXYFLAVAN; DIAZEPAM; ETOMIDATE; FLAVAN 3 OL ESTER DERIVATIVE; FLAVAN DERIVATIVE; LORECLEZOLE; PROPOFOL; THIOPENTAL; TRANS 3 ACETOXY 4' METHOXYFLAVAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MUTATIONAL ANALYSIS; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SUBUNIT; VOLTAGE CLAMP; WILD TYPE; XENOPUS;

ANIMALS; BINDING SITES; ESTERS; FLAVONOIDS; GABA-A RECEPTOR ANTAGONISTS; LIGANDS; OOCYTES; POINT MUTATION; PROTEIN SUBUNITS; RECEPTORS, GABA-A; XENOPUS LAEVIS;

EID: 84856297464     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01615.x     Document Type: Article

References (43)

1. A receptor α1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol 74: 614-627.
2. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
3. A receptor. Nat Rev Neurosci 6: 565-575. (Pubitemid 40942823)
4. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ, (1997). The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci USA 94: 11031-11036.
5. A and glycine receptors. Neurochem Int 34: 447-452. (Pubitemid 29240641)
6. A receptor model. Neurosci Lett 418: 28-33. (Pubitemid 46602692)
7. A receptor in anesthetic modulation and direct activation. J Biol Chem 278: 42821-44288.
8. Desai R, Ruesch D, Forman SA, (2009). γ-Amino butyric acid type A receptor mutations at β2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity. Anesthesiology 111: 774-784.
9. A receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates. Pharmacol Biochem Behav 90: 1-8.
10. A receptor alpha subunits that regulate the agonist action of pentobarbital. J Pharmacol Exp Ther 318: 1094-1101. (Pubitemid 44268315)
11. A receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice. Neuropharmacology 55: 900-907.
12. Gardner CR, (1988). Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum. Prog Neurobiol 31: 425-476.
13. Groves JO, Guscott MR, Hallett DJ, Rosahl TW, Pike A, Davies A, et al,. (2006). The role of GABA β2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole. Eur J Neurosci 24: 167-174. (Pubitemid 44050676)
14. A receptors expressed in Xenopus oocytes. Eur J Pharmacol 512: 97-104. (Pubitemid 40552793)
15. Hill-Venning C, Belelli D, Peters JA, Lambert JJ, (1997). Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor. Br J Pharmacol 120: 749-756.
16. Hoffman EJ, Warren EW, (1993). Flumazenil: a benzodiazepine antagonist. Clin Pharm 12: 641-656.
17. A receptors through two discrete transmembrane sites. Nature 444: 486-489. (Pubitemid 44809065)
18. Ito K, Yamada Y, Nakamura K, Sawada Y, Iga T, (1993). Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory. J Pharmacokinet Biopharm 21: 31-41. (Pubitemid 23261729)
19. Ito K, Asakura A, Yamada Y, Nakamura K, Sawada Y, Iga T, (1997). Prediction of the therapeutic dose for benzodiazepine anxiolytics based on receptor occupancy theory. Biopharm Drug Dispos 18: 293-303. (Pubitemid 27241146)
20. A receptor channel pharmacology. Curr Pharm Des 11: 1867-1885. (Pubitemid 40766848)
21. A receptor beta3 subunit. FASEB J 17: 250-252.
22. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL, (1998). Propofol and other intravenous anesthetics have sites of action on the γ-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 53: 530-538. (Pubitemid 28162877)
23. A receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J Neurosci 26: 11599-11605. (Pubitemid 44772131)
24. A) receptors. J Biol Chem 285: 8615-8620.
25. Little HJ, Bichard AR, (1984). Differential effects of the benzodiazepine antagonist Ro 15-1788 after 'general anaesthetic' concentrations of benzodiazepines in mice. Br J Anaesth 56: 1153-1160. (Pubitemid 14041693)
26. A-receptor expressed from rat brain α- and β-subunit cDNAs displays potentiation by benzodiazepine receptor ligands. Brain Res Mol Brain Res 8: 199-208. (Pubitemid 20225977)
27. A-receptor subtypes really occur in the brain? Trends Neurosci 19: 139-143.
28. A receptors. Mol Pharmacol 65: 1191-1197. (Pubitemid 38543489)
29. A receptors. Bioorg Med Chem 17: 7156-7173.
30. Miller PS, Smart TG, (2010). Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol Sci 31: 161-174.
31. Möhler H, Fritschy JM, Rudolph U, (2002). A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300: 2-8. (Pubitemid 34028501)
32. Nury H, Van Renterghem C, Weng Y, Tran A, Baaden M, Dufresne V, et al,. (2011). X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469: 428-431.
33. A receptor isoforms. J Neurosci 23: 8608-8617. (Pubitemid 37158760)
34. Rudolph U, Antkowiak B, (2004). Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5: 709-720. (Pubitemid 39150142)
35. Schechter MD, (1984). Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat. Prog Neuropsychopharmacol Biol Psychiatry 8: 359-364. (Pubitemid 14051213)
36. A receptor subtype, α1β2γ2. BMC Pharmacol 3: 13.
37. A receptor genes in the human genome. J Biol Chem 279: 41422-41435. (Pubitemid 39313583)
38. Stevenson A, Wingrove PB, Whiting PJ, Wafford KA, (1995). β-carboline γ-aminobutyric acid A receptor inverse agonists modulate γ-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Mol Pharmacol 48: 965-969.
39. A receptor gating and reduce etomidate modulation. Mol Pharmacol 74: 1687-1695.
40. A receptor: dependence on receptor subunit combination. Br J Pharmacol 117: 521-527.
41. A receptor beta subunit. Neuron 12: 775-782.
42. A receptors via two distinct and separable mechanisms. Nat Neurosci 3: 1274-1281.
43. Wingrove PB, Wafford KA, Bain C, Whiting PJ, (1994). The modulatory action of loreclezole at the γ-aminobutyric acid type A receptor is determined by a single amino acid in the β2 and β3 subunit. Proc Natl Acad Sci USA 91: 4569-4573. (Pubitemid 24143475)